Abstract

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone

Author(s): Riepl Mike

Issue: Sep/Oct 2021 - Volume 25, Number 5

Page(s): 372-377

Download in electronic PDF format for $75
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 1
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 2
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 3
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 4
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 5
  • Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Page 6

Abstract

Dermal healing occurs via a linear sequence of events in which growth factors cause cell proliferation and a subsequent integration of changes that involve soluble mediators, parenchymal and blood cells, and the production of extracellular matrix. Myriad factors influence the process and progress of healing damaged skin, and numerous agents have been used alone or in combination with other active substances to enable both responses to skin injury or disease. In this third article in a series on compounding for dermal healing, the role of nitric oxide in dermal repair is examined, as is the effectiveness of both sildenafil and naltrexone in promoting recovery. Also provided are compounded skin-healing formulations that proved effective when treatment with commercially manufactured medications failed.

Related Keywords

  • wound healing
  • wound closure
  • risk factors
  • nitric oxide
  • vasodilation
  • angiogenesis
  • collagen
  • inflammation
  • inflammatory stage of healing
  • dermal healing
  • nitric oxide synthase
  • inducible NOS
  • sildenafil
  • type V cGMP-dependent phosphodiesterase inhibitor
  • formulations
  • L-arginase
  • pressure ulcers
  • venous-stasis ulcers
  • naltrexone
  • opiate antagonist
  • opioid growth factor receptors
  • topical preparations
  • transdermal administration
  • skin penetration
  • dermal permeability

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • WOUND CARE
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2021
Pg. 372-377
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Author(s): Riepl Mike
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2002
Pg. 92-95
Options in Wound Care
Author(s): Kincaid Michele R
Jul/Aug 2021
Pg. 282-287
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Author(s): Riepl Mike
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 282-285
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Author(s): Riepl Mike
Mar/Apr 2021
Pg. 100-103
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 278-281
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Author(s): Riepl Mike
May/Jun 2020
Pg. 188-193
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Author(s): Riepl Mike
Nov/Dec 2021
Pg. 468-472
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Author(s): Riepl Mike
May/Jun 2020
Pg. 182-186
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Author(s): Riepl Mike
Mar/Apr 2020
Pg. 98-102
Compounding Pearls -- Wound Care: Base Selection
Author(s): Riepl Mike
Nov/Dec 2020
Pg. 501-508
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2023
Pg. 454-460
Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Author(s): Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
May/Jun 2009
Pg. 196-213
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Author(s): Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
Jul/Aug 2004
Pg. 265-267
Case Report: Wound Care of a Diabetic Foot Ulcer
Author(s): Wynn Tom
Mar/Apr 2018
Pg. 154-163
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Author(s): Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Sep/Oct 2004
Pg. 354-357
Current Topical Treatments in Wound Healing - Part 2
Author(s): Helmke Christopher D
May/Jun 2018
Pg. 182-188
Pitch Ointment: Applications in Scar and Wound Management
Author(s): Kloesel Lawson, Carvalho Maria, Banov Fabiana